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Abstract
Background: Immediate patient feedback has been shown to improve outcomes for patients in mild distress but it
is unclear whether psychiatric patients in severe distress benefit equally from feedback. This study investigates the
efficacy of an immediate feedback instrument in the treatment of patients with acute and severe psychosocial or
psychiatric problems referred in the middle of a crisis.
Methods: A naturalistic mixed diagnosis sample of patients (N = 370) at a Psychiatric Emergency Centre was
randomised to a Treatment-as-Usual (TAU) or a Feedback (FB) condition. In the FB condition, feedback on patient
progress was provided on a session-by-session basis to both therapists and patients. Outcomes of the two
treatment conditions were compared using repeated measures MANCOVA, Last Observation Carried Forward and
multilevel analysis.
Results: After 3 months, symptom improvement in FB (ES 0.60) did not significantly differ from TAU (ES 0.71)
(p = 0.505). After 6 weeks, FB patients (ES 0.31) actually improved less than TAU patients (0.56) (p = 0.019).
Conclusions: Patients with psychiatric problems and severe distress seeking emergency psychiatric help did not
benefit from direct feedback.
Trial registration: Dutch Trial Register, NTR3168, date of registration 1-9-2009
Keywords: Patient feedback, Randomised controlled trial, Crisis intervention, Efficacy, Outcome monitoring
Background
Feedback systems have been developed in recent decades
that provide therapists, patients or both with informa-
tion about patient progress on a session-to-session basis
[1–4]. The assumption in this ‘feedback-informed treat-
ment’ is that clients feel more engaged in the therapy
process and that therapists are better able to adapt their
therapeutic approach when feedback information suggests
that treatment is unsuccessful [3, 5, 6]. In a meta-analysis
incorporating nine studies, Lambert & Shimokawa [7]
found effect sizes varying from .23 to .33. They con-
cluded that the number of psychotherapy patients
who deteriorate in routine care (5–10 % in adult
psychotherapy, 14–24 % in child psychotherapy) can
be reduced by half using their feedback method.
Most feedback studies have been performed in psycho-
therapeutic settings and in samples of patients in mild
distress who are generally not suffering from major psy-
chiatric disorders.
The available studies in psychiatric samples in the last
decade show that feedback improves outcomes for those
with more severe mental health problems but that effect
sizes are reduced [8]. However, feedback systems differ
enormously with respect to the measures used and
the frequency of administration [2], and the small number
of studies and the heterogeneity of both the studies
and the feedback systems make it hard to draw general
conclusions [8].
Adding feedback may prove particularly valuable in this
psychiatric population since the non-attendance levels in
psychiatry are substantial, especially in the group with
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severe distress [5, 9]. Duncan et al. [5] state that patients
who have lost their sense of mastery and their faith in
therapy can be expected to feel empowered when their
views and preferences are explicitly taken into account in
a feedback process.
Since using feedback may prove to be a valuable tool
in psychiatric treatment, we aimed to investigate, in an
RCT, whether applying a feedback system can be effect-
ive in a psychiatric setting involving intensive outpatient
care following a crisis evaluation.
Method1
Setting
The study setting was a Crisis Intervention & Brief Therapy
team (CIBT team) in Amsterdam where patients with
severe psychiatric and psychosocial problems are treated on
an outpatient basis for a maximum of 6 months.
Patients are referred by GPs, mental-health workers
and the police. Indication for treatment by the CIBT
team is based upon the need for immediate help felt by
the patient or referring professional. ‘Crisis’ is defined as:
the patient needs help within 24 h due to a risk of
suicide, serious behavioural problems, problems with
the law and safety concerns, a sudden loss of social
support and/or need for involuntary admission.
The CIBT works from a transdiagnostic perspective,
which means that the assessment is not based solely on
the diagnostic category but on the overall presentation
of symptoms, and the needs and capacity of the patient
and relatives. The need for acute help or treatment is in-
tegrated with a diagnostic screening and interventions
are initiated immediately if necessary. The group of par-
ticipating therapists consists of a highly experienced per-
manent staff of six psychiatrists, ten social psychiatric
nurses, two psychologists and a family and marital ther-
apist. In addition, the team includes a group of - on
average - eight experienced and intensively supervised
residents in psychiatry who each work at the CIBT for a
period of six months. Clients are assigned to the duty
therapist. No selection is made based on the diagnosis of
the client or the discipline of the therapist. A total of
32 residents participated during the study period of
about three years as a whole. The team uses a systemic
approach that incorporates supportive and behavioural
interventions [10]. All patients undergo a full clinical psy-
chiatric examination. Treatment may involve pharmaco-
therapy and psycho-education and includes outreaching
care if needed.
Study design, randomisation and inclusion criteria
This study was designed as a randomised controlled trial
in ‘routine emergency care’ comparing Treatment As
Usual (TAU) with a Feedback condition (FB). The differ-
ence between TAU and FB is that, in every session in
FB, feedback was obtained from the patients about
progress in their functioning and about the therapeutic
alliance [11], and this feedback was discussed by the
therapist and the patient together. In the TAU condition,
feedback was obtained every six weeks without feeding
the results back to the patient or the therapist.
As the emergency setting made it impossible to distin-
guish in advance between patients who would be treated
in the CIBT team and patients who would be referred to
other treatment settings after the first contact, we con-
ducted a pre-randomisation procedure for including pa-
tients in the study sample [12]. A random allocation
sequence was generated using the SPSS random number
generator. Patients were assigned to the FB or TAU con-
dition by a research assistant who knew the allocation
sequence but had no information about the patients.
Intervention
Prior to the first session, a research assistant explained
the principles of the feedback system, the Patient for
Change Outcomes Management System (PCOMS), to all
patients who had been randomised to the FB condition.
Before each session, patients scored their well-being
using the Outcome Rating Scale (ORS) and immediately
received the printed score on a clipboard. The scores on
the ORS form were discussed with the therapist at the
beginning of each session. At the end of the session, the
patient evaluated the therapy session using the Session
Rating Scale (SRS) and also discussed the score with the
therapist. When the crosses on the ‘What did you think
of the session?’ form indicated reticence or plain dissatis-
faction, the reasons for being dissatisfied were discussed
with the therapist. When scores indicated general satis-
faction, as indicated by a sum score exceeding 36 [13],
the therapist asked for comments about how to improve
the therapy.
The research assistant invited patients in the TAU
condition to complete the ORS form at intake and every
six weeks after that. The score was recorded in the data-
base, and was not accessible to therapists or patients. In
both conditions, patients were asked to complete the
BSI and OQ45 questionnaires, first upon entering the
service, and then every 6 weeks up to a maximum of
24 weeks.
Training of therapists and application of feedback
Staff therapists were trained to administer, score and
provide feedback to patients on the basis of the training
manual provided for the ORS and SRS [14] before
the study started. Follow-up supervision sessions were
organised regularly during the course of the research
project to maintain adherence. Therapists were trained to
discuss the SRS score and encourage patients to express
any comments and concerns about the session by making
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suggestions about how to improve collaboration and
therefore address potential breaches in the alliance. Thera-
pists were given the discretion to decide how to interpret
and best integrate scores during the course of the treat-
ment. However, if the ORS curve showed no improvement
during the initial sessions, therapists were required to con-
sult a colleague and consider other treatment options.
Measures
Independent variables
The data collected at baseline (the emergency consultation)
were: age, gender, domestic situation, ethnicity and main
DSM IV diagnostic category.
Outcome measures
The number of therapy sessions and the duration of
treatment were derived from the patient registration sys-
tems of Arkin Mental Health Care in Amsterdam. The
link to the database of this system was established with
an encrypted code based on gender, date of birth and
the first two letters of the family name. This link made it
possible to deduce data for unique patients.
Choice of feedback system
In meta-analyses, three elements which make feedback
more effective were identified [2, 7]: when information
about patient progress (by contrast with information
about patient status only) was supplied, when feedback
was reported frequently (more than twice over the
course of treatment), and when both the patient and the
therapist were informed about progress. A feedback
system that incorporates these elements is the Partners
for Change Outcome Management System (PCOMS)
[13, 15]. An advantage of PCOMS is that it uses much
shorter score lists than other systems, which is important
for psychiatric patients with short attention spans. Three
randomised controlled studies have been performed with
PCOMS [16–18]. In these studies - which took place in
student and family counselling settings - patients and cou-
ples in the feedback condition were found to improve
more than patients receiving treatment as usual.
The Partners for Change Outcome Management System
(PCOMS)
PCOMS [13, 15] comprises two very short (VAS) scales
consisting of four items each: firstly the Outcome Rating
Scale (ORS) - which assesses change in three areas of
client functioning: individual (or symptomatic) function-
ing, interpersonal relationships, and social role perform-
ance - and the Session Rating Scale (SRS) for scoring the
quality of the working alliance.
The psychometric properties of the American and
Dutch versions of this instrument have been evaluated
[13, 15, 19, 20], resulting in coefficient alpha values
ranging from 0.84 to 0.93 for the ORS and from 0.80 to
0.90 for the SRS for both the American and Dutch ver-
sions. ORS test-retest reliability coefficients (Pearson’s r)
for both Dutch and American versions were reported ran-
ging from 0.49 to 0.66, and from 0.49 to 0.65 for the SRS.
With respect to this relatively weak test-retest reliability,
Hafkenscheid et al. [19] point out that correlations be-
tween subsequent administrations are an inappropriate
operational definition of test-retest reliability for instru-
ments designed to be sensitive to a client’s perception of
subjective change.
Outcome Questionnaire 45 (OQ45)
The OQ45 [21] consists of 45 statements in three subscales
that assess Symptom Distress (SD), Social-Role functioning
(SR) and Interpersonal Relationships (IR). Jong et al. [22]
conducted a psychometrical evaluation of the Dutch ver-
sion of the questionnaire. Internal consistency (alpha) for
the Total score obtained with the Dutch OQ-45 ranges
from 0.92 to 0.96. Test-retest reliability (Pearsons’s r)
ranges from 0.79 to 0.82.
The Brief Symptom Inventory (BSI)
The BSI [23] is the concise version of the Symptom
Checklist 90 (53 statements) for measuring symptoms of
psychopathology in adults. Reliability (alpha coefficient)
for the Dutch version of the scale as a whole is .96 [24];
test-retest reliability (Pearons’s r) is 0.90.
Attitude survey
In order to check for bias resulting from changes in
therapists’ attitudes to applying feedback, therapists were
asked to complete an attitude survey [16] at the start
and finish of the study consisting of 19 statements
reflecting therapist opinions about PCOMS, examples
being ‘I consider this instrument useful’ or ‘I don’t think
this instrument is useful for clients’. This survey has not
been evaluated psychometrically (Additional file 1).
Changes in attitudes towards the feedback process were
tested between baseline and 12 weeks (paired t-test).
Adherence survey
After one year (halfway through the study,) staff thera-
pists were asked, in order to check for bias in the results
due to lack of adherence, to complete an anonymous
survey about the extent to which they had been able to
apply the feedback as intended (Additional file 2).
This survey was designed by the first author and con-
tains two items:
a) the percentage of sessions in which the therapists
applied the feedback measures adequately (results
categorised in: ‘10–40 %’, ‘40–70 % and ‘more than
70 % of the sessions adequately applied’);
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b) the time spent (in minutes) discussing the ORS;
c) the time spent discussing the SRS.
Data analysis
Sample size calculation
With two groups of 90 patients, an alpha of 0.05
(one-tailed), an effect size of about 0.3 on the BSI total
score (Global Severity Index) at 12 weeks (mean EXP
group = 1.0; mean TAU= 1.3; standard deviation at week
12 is 0.80) can be detected with a statistical power of
80 %. Analysis was performed using to the intention-to-
treat principle. Sample size was calculated a priori. No
separate power analysis was performed for the ORS and
OQ45 since the BSI was the primary outcome measure, as
established beforehand [11].
Baseline characteristics were compared using Chi-square
tests, ANOVA and Mann-Whitney tests. The proportions
of early treatment termination and non-response (patients
still in treatment without measurement) were compared at
6, 12, 18 and 24 weeks using Chi-square tests. To test for
selective drop-out at these measurement points, patient
characteristics (including diagnostic categories), baseline
measurements and the number of sessions were compared.
Outcomes of the two treatment conditions (observed
cases) were compared using repeated measures
MANCOVA with the number of sessions as a covariate.
In this analysis, each subsequent measurement was
compared separately with the baseline measurement.
An identical analysis was performed on a dataset on
which Last Observation Carried Forward (LOCF) had
been performed.
Furthermore, multilevel analysis (MLwiN v2.25)
was used to establish time by treatment interactions
in ORS, BSI and OQ45. Three levels were included:
patient, therapist and time. First, the measurements
from start to week 12 (T0,T6,T12) were analysed,
followed by the measurements from start to week 24
(T0,T6,T12,T18,T24). The number of sessions was in-
cluded as a covariate.
Analyses conducted to compare the outcomes of com-
pleted treatments were based primarily on observed
cases. LOCF and multilevel analysis were used as an
additional method, primarily with the aim of comparing
the results of terminated treatments with different dura-
tions. Secondly, both LOCF and multilevel analysis were
used to handle data that were incomplete due to missing
scores and ‘drop-out’ (in other words, clients who termi-
nated treatment without mutual consent).
Pretreatment-posttreatment effect sizes for each treat-
ment group were calculated by dividing the mean differ-
ence by the pooled standard deviation of the baseline
measurement and the measurement point concerned.
In addition, the numbers of patients profiting from
treatment in both conditions were compared. Based on
Cohen’s d [25] a cut-off was established at an effect size
of 0.5 (which means a ‘medium’ effect). Clients showing
an increase > 0.5 SD on GSI were classified as ‘improved’,
clients showing an increase < 0.5 SD as ‘not changed’
and clients dropping > 0.5 SD as ‘deteriorated’. In all
analyses α = 0.05 (two-sided) was used as the level of
significance. All statistical analyses, except multilevel
analysis, were conducted in SPSS 17.0.
Results2
Patient sample
Between 2009 and 2012, a total of 861 patients were re-
ferred to the Psychiatric Emergency Centre. The 222 pa-
tients who were unable to fill out a questionnaire at
intake were excluded. A group of 269 patients were of-
fered only one session for crisis evaluation, resulting in
either immediate admission to a psychiatric hospital or
referral to the patient's own general practitioner/therap-
ist (when no indication for acute psychiatric help was
found). In 370 patients the crisis intervention was
followed by brief therapy, which was defined as more
than two sessions (including the first crisis evaluation
session). Of these patients, 83 terminated treatment
within six weeks, making it impossible to assess their
progress at the first time point (T6). The study sample
therefore included 287 patients (Fig. 1). As 94 patients
terminated treatment before T12, 49 (17.1 %) did not
complete the questionnaires at this time and 15 (5.2 %)
refused to participate, a total of 129 patients had re-
ceived either TAU (57) or TAU + FB (72) at 12 weeks.
In conclusion, score evaluation at T6 and T12 was not
possible for some of the study sample of 287 patients.
LOCF and multilevel analyses were performed to correct
for missing data.
Sample characteristics and representativeness testing
Of the participants in the total study sample (n = 287) –
FB and TAU conditions combined – 135 (47 %) were
men and 152 (52 %) were women. The mean age was
38 years, with the majority (58 %) being in the 30–49
age category (Table 1). The most common diagnostic
categories were adjustment disorder (21 %), depression
(19 %) and psychosis (15 %). About 40 % (42 %) of the
patients were Dutch-born; about 60 % had their roots
elsewhere. A substantial proportion (45 %) were living
alone. On average, patients suffered from severe distress,
as indicated by a mean BSI score of 1.84 at T0, which is
significantly lower than the mean BSI score in Dutch
clinical populations (1.23) found by de Beurs [24]. No
differences for any baseline characteristic (including
diagnostic categories) were found (Table 1), indicating a
successful randomisation procedure.
The average number of treatment sessions offered to
all patients was 9.3 (SD 5.05). No differences were found
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between conditions. The average duration of treatment
was 105 days (range 0–231 days). The majority of pa-
tients (49.9 %) ended treatment within three months,
two-thirds of patients (55.8 %) finished treatment within
eight sessions and half of all patients (49.5 %) had 4–8
sessions. There were no significant differences in treat-
ment duration between the two conditions: the mean
was 105.4 days (SD 51.81) for patients in TAU and 103.5
(SD 50.23) days for patients in FB. In addition, no rela-
tionship was found between diagnostic categories and
the average number of sessions or duration of treatment
(data not shown).
Does systematic session-by-session feedback improve
outcome?
After six weeks of treatment, patients in the TAU condi-
tion – based on observed cases analysis – had improved
by .58 on the GSI score (from 1.88 at T0 to 1.30 at T6);
patient scores in the FB condition had improved by
.31 (from 1.80 at T0 to 1.51 at T6). Patients in TAU
achieved significantly higher treatment gains than patients
in FB (p = 0.020). LOCF (p = 0.021) and multilevel analysis
(p = 0.006) produced similar GSI results at six weeks
(Table 2).
The OQ45 total score at 6 weeks was significantly
different with LOCF (p = 0.035) and multilevel analysis
(p = 0.047), and also favoured TAU.
At the predetermined primary measurement point
– the GSI at 12 weeks [11] – no significant differ-
ence in treatment gains was found between the con-
ditions: on the basis of observed cases, patients in
the TAU condition reported mean treatment gains of
0.62 (GSI decreased from 1.88 at T0 to 1.26 at T12);
this gain was 0.58 in the FB condition (GSI decreased
from 1.80 at T0 to 1.22 at T12). The ORS score at 12
weeks did not indicate any significant difference
favouring FB. LOCF and multilevel analysis also pro-
duced no significant differences or trends in total
scores at 12 weeks.
Table 3 shows that patients in TAU at 6 weeks did sig-
nificantly better on the BSI subscale (depression, hostility,
somatic complaints and anxiety) and the OQ 45 subscale
(severity). Six other scales/subscales did indicate not-
significant differences favouring TAU (from p = 0.053
to p = 0.093). There were only two subscales that did
not significantly favour FB (p = 0.055 and p = 0.069).
To test for selective treatment termination in the first
period, we looked for differences between the total study
sample at 12 weeks (N = 129) and the group of clients
eliminated from analysis due to early treatment termin-
ation or not filling out the forms (N = 158). This check
involved the same items, plus the number of sessions
and duration of treatment. Furthermore, we looked
for differences between TAU (N = 57) and FB (N = 72)
at 12 weeks, checking for the percentage of non-
responding clients still in treatment (N = 64) as well
as the percentage of all non-responding clients, in-
cluding those who terminated treatment before 12 weeks
(N = 158). We also checked for differences between
the two conditions in terms of the percentage of clients
who terminated the treatment without mutual con-
sent (in other words, drop-out patients), looking at
the total percentages in both conditions and at the
separate measurement points. Neither of these com-
parisons revealed significant differences, suggesting
that differences in treatment gains between TAU and
FB were not affected by selective early treatment ter-
mination, missing data or drop-out.
Fig. 1 Participant flow
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Table 1 Baseline characteristics of TAU versus FB condition at T0 (measurement at start of treatment)
Variable TAU condition (n = 138) FB condition (n = 149) Total group (n = 287) p*
Age, mean (sd) 38.1 (11.31) 38.2 (11.20) 38.1 (11.24) 0.934
Age subgroups 0.970
Gender, n (%): 0.346
-male 69 (50.0) 66 (44.3) 135 (47.0)
-female 69 (50.0) 83 (55.7) 152 (53.0)
Cultural background, n (%): 0.522
- Dutch 54 (39.1) 67 (45.0) 121 (42.2)
- Surinam 7 (5.1) 8 (5.4) 15 (5.2)
- Turkish 2 (1.4) 5 (3.4) 7 (2.4)
- Moroccan 11 (8.0) 6 (4.0) 17 (5.9)
- other 28 (20.3) 31 (20.8) 59 (20.6)
- unknown 36 (26.1) 32 (21.5) 68 (23.7)
Living situation, n (%): 0.181
- alone 56 (40.6) 74 (49.7) 130 (45.3)
- with children without partner 9 (6.5) 13 (8.7) 22 (7.7)
- with parents in family 10 (7.2) 3 (2.0) 13 (4.5)
- with partner 32 (23.2) 25 (16.8) 57 (19.9)
- other 14 (10.1) 15 (10.1) 59 (20.6)
- unknown 17 (12.3) 19 (12.8) 36 (12.5)
Well-being/Severity of complaints at T0. mean (SD):
GSI 1.87 (0.84) 1.80 (0.90) 1.84 (0.87) 0.453
OQ 45 total score 93.99 (27.46) 90.18 (29.31) 91.97 (28.46) 0.302
ORS 12.84 (8.76) 13.36 (9.21) 13.10 (8.99) 0.628
Diagnosis: 0.663
- psychotic disorder 23 (16.7) 21 (14.1) 44 (15.3)
- depression 29 (21.0) 25 (16.8) 54 (18.8)
- adjustment disorder 29 (21.0) 31 (20.8) 60 (20.9)
- personality disorder 15 (10.9) 13 (8.7) 28 (9.8)
- psychosocial problems 8 (5.8) 8 (5.4) 16 (5.6)
- other 30 (21.7) 42 (28.2) 72 (25.1)
- unknown 4 (2.9) 9 (6.0) 13 (4.5)
Referring service: 0.626
GP 14 (10.1) 21 (14.1) 35 (12.2)
Mental health Service 18 (13.0) 22 (14.8) 40 (13.9)
Patient 4 (2.9) 9 (6.0) 13 (4.5)
Family/friends 70 (50.7) 63 (42.3) 133 (46.3)
ER 2 (1.4) 3 (2.0) 5 (1.7)
Public Health (GGD) 2 (1.4) 3 (2.0) 5 (1.7)
Other 19 (13.8) 15 (10.1) 34 (11.8)
Unknown 9 (6.5) 13 (8.7) 22 (7.7)
* ‘Unknown’ is excluded in p-analysis
van Oenen et al. BMC Psychiatry  (2016) 16:110 Page 6 of 11
Table 2 The efficacy of the feedback interventions Total scores for BSI (GSI score), Q 45 and ORS, observed cases (OC), Last
Observation Carried Forward (LOCF) and Multilevel analyses (ML)
Time in weeks TAU Mean score (sd), N FB Mean score (sd), N p OC p (F) LOCF p ML
GSI
0 wks 1.88 (0.84) N = 138 1.80 (0.90) N = 149 ns ns ns
6 wks* 1.30 (0.82) N = 92 1.51 (0.90) N = 96 0.020 0.021 0.006
12 wks** 1.26 (0.81) N = 57 1.22 (0.84) N = 72 ns ns ns
18 wks 1.35 (0.85) N = 35 1.25 (0.79) N = 36 ns ns ns
24 wks 0.92 (0.77) N = 22 1.07 (0.66) N = 30 ns ns ns
OQ45 (total score)
0 wks 93.99 (27.46) N = 113 90.18 (29.31) N = 127 ns ns ns
6 wks 82.35 (28.68) N = 71 85.61 (29.42) N = 71 0.065 0.035 (4.476) 0.047
12 wks 81.98 (25.59) N = 44 79.56 (29.13) N = 59 ns ns ns
18 wks 77.82 (33.03) N = 25 77.55 (29.72) N = 21 ns ns ns
24 wks 71.47 (30.73) N = 16 67.49 (27.14) N = 20 ns ns ns
ORS
0 wks 12.8 (8.76) N = 134 13.4 (9.21) N = 148 ns ns ns
6 wks 18.7 (8.94) N = 86 18.1 (10.83) N = 130 ns ns ns
12 wks 19.8 (8.88) N = 57 17.8 (9.54) N = 91 ns ns 0.0503
18 wks 19.0 (9.81) N = 30 19.3 (9.73) N = 55 ns ns ns
24 wks 20.0 (8.31) N = 21 21.7 (10.48) N = 37 ns ns ns
Mean scores refer to Observed Cases
Multilevel analyses, taking into account the levels of the patient, therapist and time, showing time by treatment interactions in ORS, BSI and OQ45 (from start to
T6, T12,T18,T24)
Data in bold are significant scores; score favouring FB is indicated in italics
*99 clients (34.5 %) did not fill in forms at T6 despite being in treatment
**64 clients (22.3 %) did not fill in forms at T12 despite being in treatment
Table 3 The efficacy of the feedback interventions Significant outcomes and trends in BSI subscales and OQ45 subscales based on
observed cases, LOCF analyses and Multilevel (ML) analyses
Weeks Subscale TAU Mean score (sd), N FB Mean score (sd), N p OC p (F) LOCF p ML
BSI
6 wks Depression 1.70 (1.11) N = 91 2.04 (1.21) N = 96 0.043 0.037 (4.371) 0.008
Hostility 0.91 (1.04) N = 93 1.09 (0.99) N = 96 0.018 0.018 (5.676) 0.013
Somatic 0.94 (0.81) N = 91 1.21 (0.96) N = 96 0.079 0.079 0.026
Cognitive 1.66 (1.04) N = 92 1.87 (1.09) N = 96 0.088 0.087 0.065
Anxiety 1.45 (1.00) N = 92 1.70 (1.17) N = 96 0.060 0.067 0.028
Interpersonal 1.36 (1.08) N = 92 1.47 (1.11) N = 96 ns ns 0.084
12 wks Interpersonal 1.22 (0.92) N = 58 1.28 (1.00) N = 72 0.071 ns 0.075
18 wks Hostility 1.07 (1.11) N = 35 0.77 (0.86) N = 36 0.069 ns Ns
24 wks Depression 1.11 (0.90) N = 21 1.56 (0.95) N = 30 ns 0.055 0.070
OQ45
6 wks Severity 44.92 (17.01) N = 71 47.17 (18.03) N = 72 0.035 0.017 (5.780) 0.024
12 wks Socially 15.63 (4.51) N = 37 16.28 (6.18) N = 52 0.083 ns 0.093
Severity 44.03 (15.75) N = 44 43.80 (16.88) N = 60 ns 0.055 Ns
24 wks Severity 36.57 (17.90) N = 16 38.10 (16.46) N = 20 ns 0.053 Ns
Mean scores refer to observed cases
All subscores favour the TAU condition, with the exception of the BSI Hostility score (only OC) at 18 weeks and O 45 severity at 12 weeks (only LOCF); scores
favouring FB are indicated in italics, data in bold are significant scores
Multilevel analyses, taking into account the levels of the patient, therapist and time, showed time by treatment interactions in ORS, BSI and OQ45 (from start to
T6, T12,T18,T24)
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What do the differences in treatment gains mean in
clinical practice?
To identify the significance of the differences in treat-
ment gains for clinical practice, final outcomes were
categorised according to the percentages of patients
who did and did not benefit from treatment according to
the GSI (Table 4).
At T6, significantly (p = 0.006) more patients in FB
(68.8 %) had undergone no change or deterioration (in
other words, their scores fell by > .5 SD on GSI) than in
TAU (48.9 %). At twelve weeks these differences were
no longer statistically significant: in FB 48.6 % of the
patients showed ‘no change’ or ‘deterioration’, as op-
posed to 45.7 % in TAU. In the full sample 52.7 % of
patients had improved at T12 and 67.3 % had done so
at T24.
Table 5 presents the effect sizes (ES) of treatment.
The ES for the TAU group at week 6 was .56 (sd 0.70), as
opposed to .31 (sd 0.76) for the FB group, which is a sig-
nificant difference in favour of the TAU group (p = 0.019).
There were no significant differences in ES at other meas-
uring points.
Therapist attitude and adherence
Fifty-one therapists (19 staff members and 32 residents)
completed an adherence and attitude survey at both the
beginning and the end of the study. The mean score
at the beginning was 73.88 (SD 9.29) out of 95 and 71.96
(SD 8.01) at the end, indicating that therapists’ attitudes to
feedback were very positive on average, even though the
initially high motivation of the therapists eroded slightly,
albeit not significantly, over time (p = 0.06). In the adher-
ence survey, 67 % of the staff therapists reported that they
had applied PCOMS adequately in more than 70 % of the
sessions; 14 % had applied it in 40–70 % of the sessions,
and 19 % in 10–40 %. On average, therapists (N = 21) esti-
mated that they spent 3.5 min on the ORS and 4 min on
the SRS. Almost all patients completed the ORS and SRS
forms: only one patient did not fill out a single ORS form,
and two patients did not fill out a single SRS form.
Discussion
This study was set up to determine whether the positive
results of immediate feedback described in psychother-
apy studies could also be demonstrated in short-term
Table 4 Deterioration, no change and improvement based on GSI
TAU FB Total Comparison TAU and FB:
N % N % N % Chi2 p
T6 deterioration 5 5.4 9 9.4 14 7.4 7.645 0.007
no change 40 43.5 56 59.4 96 51.1
Improved 47 51.1 31 32.3 78 41.5
T12 deterioration 3 5.3 6 8.30 9,0 7.0 .115 0.360
no change 22 38.6 29 40.3 51 39.5
Improved 32 56.1 37 51.4 69 53.5
T18 deterioration 1 2.9 3 8.3 4 5.6 .688 .205
no change 17 48.6 11 30.6 28 39.4
Improved 17 48.6 22 61.1 39 54.9
T24 deterioration 1 4.5 1 1.9 .234 .562
no change 6 27.3 9 30.0 15 28.8
Improved 15 68.2 21 70.0 36 69.2
Improved: increase > 0.5 SD on GSI
No change: improvement < 0.5 SD on GSI
Deterioration: dropping > 0.5 SD on GSI
Comparison TAU versus FB:% improved (> .5 SD increase) and % not improved (< .5 SD increase, i.e. ‘no change’ and ‘deterioration’ combined) in both conditions
were compared. Data in bold are significant scores
Table 5 Effect sizes TAU and FB on different measuring points, based on GSI scores
(d, N, sd) TAU EXP Full sample F p
ES GSI T6 0.56 (N = 92; sd0.70) 0.31 (N = 96; sd0.77) 0.44 (N = 188; sd0.74) 5.575 0.019
ES GSI T12 0.73 (N = 57; sd0.88) 0.62 (N = 72; sd0.95) 0.67 (N = 129; sd0.92) 0.446 0.505
ES GSI T18 0.60 (N = 35; sd0.77) 0.70 (N = 36; sd0.74) 0.65 (N = 71; sd0.75) 0.275 0.602
ES GSI T24 1.13 (N = 22; sd1.20) 0.86 (N = 30; sd0.82) 0.98 (N = 52; sd0.99) 0.921 0.342
d ¼ Estimate Tx‐Estimate pretreatment
SD pretreatmentð Þ2þ SD Txð Þ2f g=2
Data in bold are significant scores
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psychiatric treatment delivered in an outpatient emer-
gency centre for a range of problems and disorders. Con-
trary to what we expected, we found no positive effect of
immediate feedback at the predetermined end point of
our study at twelve weeks. Furthermore, the effect was
negative at six weeks because there was significantly less
improvement in the FB condition than in the TAU condi-
tion. More patients in the FB condition were ‘not on track’
(showing no change or deterioration) during the treat-
ment process. No difference was found between the TAU
and FB groups with respect to duration and number of
sessions. Comparing non-responding clients revealed no
significant differences, suggesting that providing feedback
did not influence selective drop-out in a positive way.
It can be concluded that we found no advantage to in-
cluding feedback in an emergency psychiatry setting. This
result clearly contrasts with most of the earlier studies of
PCOMS, which have found substantial benefits with feed-
back in other treatment settings [16–18]. Three possible
clinical explanations can be offered for our findings.
Reduced ability to reflect during crisis
Characteristically, in crisis situations, people’s ability to con-
sider alternatives and reflect on their situation is impaired
[10]. Since the ability to reflect and consider alternatives are
precisely the elements needed to benefit from feedback, it
is plausible that the impairment of those abilities is respon-
sible (in whole or in part) for the lack of effect of feedback.
Apart from this, patients in crisis desperately look for
solutions, including someone who can offer a way out.
Explicitly stressing shared responsibilities, as well as pos-
sibly introducing insecurity about different treatment
options and outcome at the outset in a crisis situation
might actually burden the therapeutic relationship. For-
malising feedback may disturb the process of subtly bal-
ancing between sharing responsibilities for the content
of treatment and taking responsibility for the form of
the treatment process, which is part of the art of crisis
intervention [10].
The finding that differences in favour of TAU emerged
in the first six weeks can be interpreted in line with this
explanation since, in the initial weeks, a crisis is more
severe and the ability to reflect is poor. Later on – as pa-
tients stabilise more – immediate feedback is probably
more acceptable to patients, even though it still does not
lead to better outcomes.
Low level of functioning and severity of psychiatric
problems interfere with feedback effects
Simon et al. [26] found that feedback had less effect (d = .12
versus d = .30) in a sample with lower pre-test scores
(OQ score 83.72) than in a sample with higher pre-test
scores (mean OQ 88.8) in a previous study in the same
clinic [27]. They suggested that the difference in pre-test
scores could account for the reduced effect of feedback,
and that ‘feedback interventions do not work as well with
more disturbed patients as with the less disturbed’.
The pre-test scores found in our study indicate a higher
level of distress than the pre-test scores in other feedback
studies. The average ORS score was 13.3 (sd 9.14), as
compared with 18.33 to 23.7 in other studies [15–18]; the
mean pre-test OQ45 sum score was 91.78 (sd 27.80), as
compared with 68 to 78 in other studies [28–30] (a lower
OQ score means less severe complaints).
The low pre-test scores in our study may have been
confronting for patients in FB and discouraging for pa-
tients who dysfunction in several life domains. Any posi-
tive effect of the feedback process would not seem to
compensate for this drawback.
Relatively high efficacy of TAU
It should be noted that the effect size in the TAU condi-
tion in our study (0.71 at twelve weeks) is relatively high
by comparison with the TAU groups in other feedback
studies: Harmon et al. [29] report 0.43, Hawkins [27] .63
and Reese [18] .38. It is possible that this did not leave
an adequate margin for further improvement as a result
of adding feedback to this treatment.
Method: strengths and limitations
Limitations
This study took place in a naturalistic crisis setting and
the implementation of the study was therefore challenging
in several ways. Firstly, a pre-randomisation procedure
had to be conducted instead of random assignment with a
full evaluation of inclusion and exclusion criteria before
initiating randomisation. Secondly, therapies inevitably
differed in duration and intensity, and there was some-
times a change of therapist in the course of therapy. How-
ever, analyses based on observed cases, LOCF and
multilevel analysis – with the latter two adjusting for miss-
ing data – lead to consistent results, suggesting that the
overall conclusions are sound. A drawback in the design
was that patients in the TAU group completed the ORS
forms only every six weeks (to prevent bias coming from
frequent ‘feedback-alike’ reflection on progress in TAU
group), making it impossible to compare on-track/not-on-
track trajectories in the two conditions. As a consequence,
no conclusions can be drawn about the specific effect of
feedback on the group of not-on-track patients. Neverthe-
less, the finding that a comparison of early termination
and non-response in both conditions did not reveal differ-
ences suggests that early identification of not-on-track pa-
tients did not improve outcomes.
Another limitation is that data was not collected about
co-existing treatment and the use of medication during the
study and so it is not known whether these factors have in-
fluenced the outcome or selective drop-out. Even so, no
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differences were found in the drop-out rates for the differ-
ent diagnostic categories and it therefore seems unlikely
that medication use – which is generally linked to diagnos-
tic categories – affected the outcomes. Sub-analyses by
diagnostic group did not reveal significant differences.
However, observed power was limited and so it is difficult
to draw conclusions from these analyses. Finally, the adher-
ence of the therapist to the feedback model was monitored
by self-report and peer supervision but not measured
systematically.
Strengths
The setting and population of this study are unique. No
feedback study has yet been performed to our knowledge
of patients in crisis suffering from severe psychiatric and
psychosocial problems. The design ensures that possible
differences in therapist characteristics are not responsible
for differences in outcome: patients were allocated ran-
domly to the different study conditions, and therapists –
all of whom were experienced and qualified care providers
– participated in both conditions and therefore treated ap-
proximately 50 % of their patients using PCOMS and 50 %
on the basis of TAU. Given the fact that differences be-
tween therapists are usually more pronounced than differ-
ences between therapeutic methods, it is important to
eliminate the therapist variable [31]. The flip side to this
strength is a possible spill-over effect that may occur if
therapists fail to distinguish clearly between both condi-
tions. Another benefit of this design is that it is not very
likely that allegiance factors (in other words, therapists be-
lieving in the effect of feedback) affected outcomes because
therapists with both higher and lower levels of motivation
delivered treatment to the Feedback condition.
A final strength of the study is that, contrary to previous
studies, independent outcome measures (BSI and Q45)
were provided instead of using the feedback measure
(ORS) itself as an outcome measure. Providing outcome
information to patients may result in ‘demand characteris-
tics’ (patients responding to incidental hints about the ther-
apists’ expectations) that favour the feedback condition
[32, 33]. In line with this, Janse [34] has recently argued
that, although PCOMS is a useful feedback instrument, its
validity is limited and therefore other instruments should
be added to corroborate progress. Ideally, studies should
therefore use an independent outcome measure that is not
discussed with the therapist.
In our study, the adverse effect of applying feedback
would not have been revealed if BSI and OQ45 had not
been added. This finding could suggest that ORS outcomes
have indeed been influenced by ‘socially desirable’ scoring.
Conclusions
To our knowledge, this is the first study suggesting
that immediate progress feedback in psychiatric practice
does not improve outcome and that it may even be
counterproductive.
Perhaps patients did not benefit from feedback be-
cause they were unable or reluctant to think about the
treatment process, and confronting them repeatedly with
their low level of functioning may have demoralised
them. If this is true, it may be better not to subject some
patients with immediate feedback. Future research could
determine whether pre-treatment functioning and the
patient’s ability to reflect influence the success of feed-
back. In studies of this kind, independent outcome mea-
sures should be added to control for ‘socially desirable’
scoring during the feedback process.
Availability of data and materials




Ethics approval and consent to participate
The study protocol and informed consent procedure
were evaluated in 2009 by the ethics committee for
Dutch Mental Health Institutions, (Kamer Noord of the
METiGG) (approval nr. 9219, 1-9-2009). Following their
conclusion, the Committee concluded that, since feed-
back does not fall under the jurisdiction of the WMO
(the Dutch law on scientific medical research on human
subjects), the regular clinical procedure for informed
consent at the department could be followed. The study
was then explained to the patients, written information
was provided and patients were asked to participate on a
voluntary basis, which was noted in the medical file.
Endnotes
1For a more detailed description of treatment ele-
ments, randomisation procedure, training of therapists
and interpretation of feedback measures, see van Oenen
et al. [10, 11].
2Scores for alliance scales (Session Rating Scale and
HAQ2) will be reported and discussed in a separate paper.
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Additional file 1: Attitude survey. Therapist’s attitude to applying
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Additional file 2: Adherence Survey. Adherence of therapists to
feedback method (DOCX 14 kb)
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